Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractional Shares

1,514.97
+5.770.38%
Number of Gainers:804
Number of Losers:209
Number of Flat:21
PE:- -
High:1,516.81
Open:1,509.59
Low:1,505.09
Close:1,509.19
Loading ...

Millions of Résumés Never Make It Past the Bots. One Man Is Trying to Find Out Why. -- WSJ

Dow Jones
·
14 hours ago

Analysts Offer Insights on Materials Companies: PPG Industries (PPG) and Fortescue Metals Group Ltd (OtherFSUMF)

TIPRANKS
·
14 hours ago

ASX ALERT-$113M AngloGold Tenement Option Agreement now Unconditional-MAT.AX

Reuters
·
14 hours ago

HSBC Executes Major Share Buy-Back to Optimize Capital Structure

TIPRANKS
·
14 hours ago

Richmond Vanadium Technology Adapts Strategy Amid Market Challenges

TIPRANKS
·
14 hours ago

Southern Cross Gold Consolidated Issues Restricted Stock Units

TIPRANKS
·
14 hours ago

BHP Group Ltd (BHPLF) Receives a Buy from Citi

TIPRANKS
·
14 hours ago

Appendix 3C-NWSA.O

Reuters
·
14 hours ago

Notification of cessation of securities - NWS-NWSA.O

Reuters
·
14 hours ago

Wolfspeed entered into Restructuring Support Agreement with key lenders

TIPRANKS
·
15 hours ago

BRIEF-Renesas Says Expected Loss Resulting From Signing Restructuring Support Agreement With Wolfspeed

Reuters
·
15 hours ago

Chipmaker Wolfspeed Reaches Agreement with Creditors, Plans Bankruptcy Filing

Reuters
·
11 hours ago

FireFly Metals Completes Significant Equity Raising Initiative

TIPRANKS
·
15 hours ago

Press Release - CEO Employment Agreement Extension-NWSA.O

Reuters
·
15 hours ago

Commentary: Tragic Air India crash puts Boeing’s Dreamliner in safety spotlight, again

CNA
·
16 hours ago

Australia CPI to Stay Stable at 2.4%; Core Inflation to Hold Steady, Morgan Stanley Says

MT Newswires Live
·
16 hours ago

News Corp extends contract with CEO Thomson through June 2030

TIPRANKS
·
16 hours ago

Laidlaw, MacKenzie among candidates considered for BP chairman, Sky News says

TIPRANKS
·
16 hours ago

Should You Forget Bitcoin and Buy Solana?

Motley Fool
·
16 hours ago

Novo Nordisk presented results from its Phase 3b FRONTIER5 trial on Mim8

TIPRANKS
·
16 hours ago